ONESOURCE SPECIALTY PHARMA
Back to Income Statement
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,445 Cr | ₹172 Cr | ₹39 Cr | ₹128 Cr | ₹128 Cr |
What is the latest Revenue of ONESOURCE SPECIALTY PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,445 Cr |
| Mar2025 | ₹172 Cr |
| Mar2024 | ₹39 Cr |
| Mar2023 | ₹128 Cr |
| Mar2022 | ₹128 Cr |
How is Revenue of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,445 Cr | 740.43 | |
| Mar2025 | ₹172 Cr | 344.07 | |
| Mar2024 | ₹39 Cr | -69.80 | |
| Mar2023 | ₹128 Cr | 0.00 | |
| Mar2022 | ₹128 Cr | - | |
Compare Revenue of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹18,513.7 Cr | 0.2% | 16.7% | -10.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 0.2% |
16.7% |
-10.2% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses